(19)
(11) EP 4 255 936 A1

(12)

(43) Date of publication:
11.10.2023 Bulletin 2023/41

(21) Application number: 21901383.6

(22) Date of filing: 01.12.2021
(51) International Patent Classification (IPC): 
C07K 19/00(2006.01)
C12N 15/62(2006.01)
A61K 35/17(2015.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/7051; C07K 2319/03; C07K 2319/02; A61K 39/001129; A61P 35/00; C07K 16/2878; A61K 2039/5156; C12N 2510/00; C12N 5/0636; A61K 39/0011; A61P 35/02; C07K 2317/622; C07K 2317/56; C07K 2317/565; C07K 2317/24
(86) International application number:
PCT/US2021/061410
(87) International publication number:
WO 2022/119923 (09.06.2022 Gazette 2022/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 02.12.2020 US 202063120692 P
25.02.2021 US 202163153666 P
18.06.2021 US 202163212289 P
16.09.2021 US 202117476661

(71) Applicant: Shanghai Cellular Biopharmaceutical Group Ltd.
Shanghai 201210 (CN)

(72) Inventors:
  • YAO, Yihong
    Hong Kong (HK)
  • HUANG, Jiaqi
    Hong Kong (HK)
  • YAO, Xin
    Hong Kong (HK)

(74) Representative: Cabinet Becker et AssociĆ©s 
25, rue Louis le Grand
75002 Paris
75002 Paris (FR)

   


(54) BCMA-TARGETED CHIMERIC ANTIGEN RECEPTORS